Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Influence of the apolipoprotein E type 4 allele on cerebral glucose metabolism in Alzheimer's disease patients.

The Journal of neuropsychiatry and clinical neurosciences - 1 Jan 2003

Lee Kang U, Lee Jae S, Kim Ki W, Jhoo Jin H, Lee Dong Y, Yoon Jong C, Lee Jung H, Lee Dong S, Lee Myung C, Woo Jong I

Abstract excerpt

It is still unclear whether apolipoprotein E epsilon 4 (APOE E4) influences the cerebral glucose metabolism abnormalities found in Alzheimer's disease (AD), although APOE E4 is a well-known risk factor for AD. [(18)F]Fluorodeoxyglucose PET was conducted in patients with very mild (n=17), mild (n=...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoprotein E4
Share to Apolipoproteins E
Share to Blood Glucose

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cerebral Cortex

Share to Fluorodeoxyglucose F18

Share to Genetic Carrier Screening

Share to Temporal Lobe

Share to Tomography, Emission-Computed

Source

Identifiers

PMID: 12556576
DOI: 10.1176/jnp.15.1.78

Genes

APOE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-12556576-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Influence of the apolipoprotein E type 4 allele on cerebral glucose metabolism in Alzheimer's disease patients.PMID 12556576Read ↗

Cerebral glucose metabolism in patients with AD and different APOE genotypes.Semantic proximity Read ↗

Beta-amyloid associated differential effects of APOE ε4 on brain metabolism in cognitively normal elderly.Semantic proximity Read ↗

Lack of association of apolipoprotein E epsilon4 allele dose with cerebral glucose metabolism in Alzheimer disease.Semantic proximity Read ↗

Apolipoprotein E, not fibrillar β-amyloid, reduces cerebral glucose metabolism in normal aging.Semantic proximity Read ↗

Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease.Semantic proximity Read ↗

The effect of APOE epsilon4 allele on cerebral glucose metabolism in AD is a function of age at onset.Semantic proximity Read ↗

Effect of APOE ε4 genotype on amyloid-β, glucose metabolism, and gray matter volume in cognitively normal individuals and amnestic mild cognitive impairment.Semantic proximity Read ↗

Brain metabolic decreases related to the dose of the ApoE e4 allele in Alzheimer's disease.Semantic proximity Read ↗

Age and ApoE genotype interaction in Alzheimer's disease: an FDG-PET study.Semantic proximity Read ↗

No difference in cerebral glucose metabolism in patients with Alzheimer disease and differing apolipoprotein E genotypes.Semantic proximity Read ↗

Apolipoprotein E polymorphism influences the cerebral metabolic pattern in Alzheimer's disease.Semantic proximity Read ↗

Imaging brain effects of APOE4 in cognitively normal individuals across the lifespan.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.